Invistics

NIH Research Increases Detection of Drug Diversion and Opioid Theft within U.S. Hospitals

05/08/2018

NIH and Invistics use Machine Learning and Advanced Analytics to Identify Threat of Diversion more Effectively and Efficiently than Traditional Hospital Standards. ATLANTA, GA May 08, 2018 Invistics the leading provider of advanced healthcare inventory visibility and analytics software, today… more →

2017 Controlled Substance Compliance Conferences Invistics will be Attending

04/09/2017

The Invistics team will be attending the following upcoming events for Controlled Substance Compliance in 2017. We’ll be there to learn as much as possible about the latest news and technology in the industry. Come say hi! We welcome a… more →

Invistics Releases Flowlytics v7.0 with New Controlled Substance Solutions

02/03/2016

Latest Flowlytics® software suite implementation adds new features to our Controlled Substance solution that improves Drug Enforcement Agency (DEA) reporting, provides visibility into lot lineage, and gives better control for software user management. ATLANTA (February 1st, 2016) Invistics®, the recognized… more →

Invistics Introduces Promise Date Finder to quote reliable, accurate lead times

06/25/2015

Latest Flowlytics Module allows Customer Service representatives to quote reliable, accurate lead times on new orders ATLANTA (June 25th, 2015) – Invistics, the recognized leader in inventory analytics software solutions for high-mix manufacturing companies, today announced the addition of the… more →

Invistics Partners with BuzzeoPDMA, a Cegedim Company, to Offer Breakthrough Solutions for Inventory and Sample Distribution Opimization

01/15/2015

End-to-End Solution Optimizes Supply Chain Management and Enhances Compliance with DEA and FDA Regulations Bedminster, NJ – January 15, 2015 – BuzzeoPDMA, a Cegedim Company, which is focused on technology information and service solutions delivering innovation to help transform commercial,… more →